FindMyKOL
Clinical trialNCT02823327TerminatedObservational

Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma

SponsorAIDS Malignancy ConsortiumEnrollment25AIDS-Related Primary Effusion Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This research trial studies clinical factors and gene expression analysis for prognosis in tissue samples from patients with acquired immune deficiency syndrome (AIDS)-related primary effusion lymphoma. Gathering health information over time and studying samples of tissue from patients in the laboratory may help doctors learn about the prognosis of patients with AIDS-related primary effusion lymphoma.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Uc San Diego Moores Cancer Center

    La Jolla, California, United States

  • Ucla Care Center

    Los Angeles, California, United States

  • University of Miami

    Miami, Florida, United States

  • Memorial Hospital West

    Pembroke Pines, Florida, United States

  • Stroger Hospital of Cook County

    Chicago, Illinois, United States

  • Virginia Mason Medical Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 Oct 2016
Primary completion
3 Feb 2023
Completion
3 Feb 2023
Last update posted
11 May 2025
Registered enrollment
25
Registry id
NCT02823327

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.